Disclosure Of Interests In Other Entities [Text Block]

Zealand Pharma - Filing #1350008

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
Disclosure of interests in other entities [text block]
Disclosure of interests in subsidiaries [text block]
Disclosure of subsidiaries [text block]
Disclosure of subsidiaries [abstract]
Disclosure of subsidiaries [line items]
Current assets
1,779,788,000 DKK
1,316,352,000 DKK
Non-current assets
200,205,000 DKK
223,454,000 DKK
Current liabilities
284,579,000 DKK
195,491,000 DKK
Non-current liabilities
102,575,000 DKK
528,404,000 DKK
Revenue
342,788,000 DKK
103,986,000 DKK
Profit (loss)
- DKK
703,739,000 DKK
703,739,000 DKK
- DKK
- DKK
- DKK
1,202,135,000 DKK
- DKK
1,202,135,000 DKK
- DKK
Comprehensive income
695,652,000 DKK
1,201,673,000 DKK
Disclosure of interests in associates [text block]
Disclosure of associates [text block]
Disclosure of associates [abstract]
Disclosure of associates [line items]
Profit (loss) from continuing operations
703,739,000 DKK
965,610,000 DKK
Profit (loss) from discontinued operations
- DKK
236,525,000 DKK
Other comprehensive income
- DKK
8,087,000 DKK
- DKK
- DKK
8,087,000 DKK
- DKK
462,000 DKK
- DKK
- DKK
462,000 DKK
Disclosure of interests in joint arrangements [text block]
Disclosure of joint ventures [text block]
Disclosure of joint ventures [abstract]
Disclosure of joint ventures [line items]
Cash and cash equivalents
449,311,000 DKK
1,069,234,000 DKK
1,129,103,000 DKK
Tax expense (income)
5,126,000 DKK
6,431,000 DKK

Talk to a Data Expert

Have a question? We'll get back to you promptly.